HIDA Scan Market is estimated to be valued at USD 300 Million in 2024. The market expected to reach USD 493.89 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 6.43% from 2025 to 2032.
Explore additional details by clicking the link provided: https://www.maximizemarketresearch.com/request-sample/274429/
About the Market
HIDA Scan market is growing due to rising liver and gallbladder diseases, such as cholecystitis and bile duct obstructions, along with advancements in nuclear medicine and a preference for minimally invasive diagnostics. Challenges include high costs and limited access in developing countries. Recent developments include GE Healthcares CardioCare V100 Ventilator, Siemens Healthineers’ expansion in Saudi Arabia, and Mindrays affordable healthcare initiatives in Kenya, reflecting innovation and improved accessibility in diagnostics.
For a deeper understanding, click on the link below: https://www.maximizemarketresearch.com/request-sample/274429/
HIDA Scan Market Segment Analysis
In 2024, Radiopharmaceuticals Segment Held the Dominant Position with A Share of Above 30% While Hospitals Segment Dominated the HIDA Scan Market In 2024 and accounted for 55% Of the Global Revenue Share.
By Product
Radiopharmaceuticals
Gamma camera
Others
By Indentation
Cholecystitis
Bile duct obstruction
Biliary atresia
Postoperative complications
Assessment of liver transplant
By End User
Hospitals & clinics
Diagnostic centers
Others
To dive into the specifics, click the below link: https://www.maximizemarketresearch.com/market-report/hida-scan-market/274429/
HIDA Scan Market Regional Insights
In 2024, North America held the largest revenue share in the HIDA Scan Market, contributing approximately 45%, followed by Europe as the second-largest region with around 30% of the market share. These lead due to their advanced healthcare infrastructure, high prevalence of liver and gallbladder diseases, substantial healthcare spending, and strong focus on medical research and technology.
Market key players Fueling industry evolution
GE Healthcare (U.S.) $19.672 billion
Siemens Healthineers (Germany) $24.5 billion
Philips Healthcare (Netherlands) $20.8 billion
Canon Medical Systems (Japan) $8.2 billion
Hitachi Healthcare (Japan) $7.5 billion
New Related Markets Published by Maximize Market Research.
Perfusion Radiology Market: Perfusion Radiology Market was valued at USD 4.25 Billion in 2024 and the market is expected to grow at a CAGR of 8.4% throughout the forecast period, to reach USD 7.89 Billion by 2032.
Nuclear Medicine Market: Nuclear Medicine Market size was valued at USD 7.22 Bn. in 2023 and the total Insulation revenue is expected to grow by 14.7% from 2024 to 2030, reaching nearly USD 18.87 Bn.
3D Medical Imaging Market: 3D Medical Imaging Market size was valued at USD 33.76 Billion in 2023 and the total 3D Medical Imaging revenue is expected to grow at a CAGR of 6.92 % from 2024 to 2030, reaching nearly USD 53.93 Billion by 2030.